Volume 70, Issue 3, Pages (August 2006)

Slides:

Advertisements

Similar presentations

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Advertisements

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Volume 70, Issue 3, Pages (August 2006)

Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Inflammation and wasting in chronic kidney disease: Partners in crime

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Sanjeev Kumar, Stanley L.-S. Fan, Martin.

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden S.N. Davison, G.S.

Volume 73, Issue 5, Pages (March 2008)

A new era in phosphate binder therapy: What are the options?

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 77, Issue 2, Pages (January 2010)

Benefits of preserving residual renal function in peritoneal dialysis

Volume 73, Pages S5-S17 (April 2008)

Volume 133, Issue 2, Pages (August 2007)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Analgesic nephropathy

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 87, Issue 1, Pages (January 2015)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Volume 62, Issue 4, Pages (October 2002)

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 67, Issue 5, Pages (May 2005)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 71, Issue 12, Pages (June 2007)

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 77, Issue 12, Pages (June 2010)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Daily nocturnal home hemodialysis

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Volume 70, Issue 7, Pages (October 2006)

Is it the low-protein diet or simply the salt restriction?

Treatment of the primary hyperoxalurias: A new chapter

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 72, Issue 12, Pages (December 2007)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Volume 72, Issue 11, Pages (December 2007)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 74, Issue 10, Pages (November 2008)

Prediction in idiopathic membranous nephropathy

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 70, Issue 3, Pages 543-548 (August 2006) A simple score predicts future cardiovascular events in an inception cohort of dialysis patients J.P. Schwaiger, U. Neyer, H. Sprenger-Mähr, B. Kollerits, M. Mündle, M. Längle, F. Kronenberg Kidney International Volume 70, Issue 3, Pages 543-548 (August 2006) DOI: 10.1038/sj.ki.5001589 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Cardiovascular disease during observation period. (a) Kaplan–Meier curves of cardiovascular event-free survival in patients with and without previous cardiovascular events before the enrollment into the study, (b) with and without vascular calcifications at the time of enrollment, and (c) the three groups of the vascular risk score (VRS). The VRS was built by summing the presence (coded as 1) or absence (coded as 0) of vascular calcifications and of previous cardiovascular events. If a patient had none of both conditions, the score was 0, in case of one of both conditions, the score was 1, and in case of both conditions, this score was 2. Numbers near the survival curves represent the number of patients at risk within each stratum at the times 0, 24, 48, 72, 96, 120, and 144 months of observation. Kidney International 2006 70, 543-548DOI: (10.1038/sj.ki.5001589) Copyright © 2006 International Society of Nephrology Terms and Conditions